Efficacy and Safety of Rituximab Therapy for Lupus Nephritis Among SLE Female Patients; a Retrospective Hospital-Based Study

BACKGROUND: Renal affection in systemic lupus erythematosus (SLE) is a high-risk manifestation in which novel treatment strategies are required, particularly in patients who show lower response to conventional therapy. Rituximab has been used as an off-label treatment for lupus nephritis (LN) for th...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdelkarim Aloub, Khansa Osama, Eltahirm, Noha Ibrahim Ahmed, Elagib, Elnour Mohammed, Adam Essa, Mohammed Elmujtba, Hussein, Mustafa Mohammed Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9758987/
https://www.ncbi.nlm.nih.gov/pubmed/36536922
http://dx.doi.org/10.2147/OARRR.S391091

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9758987/
https://www.ncbi.nlm.nih.gov/pubmed/36536922
http://dx.doi.org/10.2147/OARRR.S391091

Ejemplares similares